c-Targeted Gene Editing for Cancer Immunotherapy
Università degli Studi di Perugia invites applications for a Research Fellow to advance gene-targeting and genome-editing strategies aimed at selectively modulating conventional type 1 dendritic cells (cDC1) in cancer immunotherapy.
Prima di candidarsi per questo ruolo, la preghiamo di leggere le seguenti informazioni su questa occasione, riportate di seguito.
The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in cDC1, with analyses xbvzest by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.
Prima di candidarsi per questo ruolo, la preghiamo di leggere le seguenti informazioni su questa occasione, riportate di seguito.
The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in cDC1, with analyses xbvzest by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.